Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03752333
Title Trial of Pembrolizumab in Cancer of Unknown Primary (CUPem)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Imperial College London
Indications

Cancer of Unknown Primary

Therapies

Pembrolizumab

Age Groups: senior | adult
Covered Countries


No variant requirements are available.